SD
Sezer Demir
View Sezer's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Manager Business Development
Present
Company Details
11-50 Employees
Following the acquisition of Lung Therapeutics in October 2023, Aileron is shifting its disease focus to advancing a pipeline of first-in-class medicines to address significant unmet medical needs in orphan pulmonary and fibrosis diseases, including LTI-03 for idiopathic pulmonary fibrosis (IPF) and LTI-01 for loculated pleural effusion (LPE). For more information about the company, please visit our website.
Year Founded
2005
Social Media
Linkedin
Industry
Biotechnology Research
HQ Location
285 Summer Street Boston, MA 02210, US
Keywords
Drug DevelopmentStapled PeptidesBiopharmaceuticalsChemistryChemoprotectioMyelopreservatioChemotherapySupportive Care
Discover More About Cleveland Clinic

Find verified contacts of Sezer Demir in seconds from 700M people profiles. Start now!

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.